Tunable wrinkled topographies direct dendritic cell maturation and immune phenotypes
Source abstract
Abstract
Dendritic cells (DCs) are potent regulators of immunity with therapeutic potential in cancer, autoimmune disorders, and implant tolerance. However, clinical translation is limited by poor scalability, limited survival/retention after delivery, and difficulty controlling DC immune responses. Biomaterials have been explored to address these challenges, but the role of surface topography in DC regulation remains poorly understood. Here, we used a custom bottom-up nanofabrication method to create wrinkled multilayer coatings with precisely tunable nano-, submicro-, and microscale topographies. Using this platform, we systematically investigated the impact of topographical cues on DC behavior, using the DC2.4 cell line and primary bone marrow-derived DCs (BMDCs) as biological models. We found that distinct topographies drive DCs toward divergent phenotypes. Microscale wrinkles promoted an immunogenic mature state, with elevated pro-inflammatory cytokines (IL-6, IL-12, and TNF-α), high co-stimulation and NF-κB activation, and strong T-cell activation potential. Submicro-scale patterns induced an intermediate mature state with homeostatic and tolerogenic potential. Submicro exhibited increased TGF-β and IL-10, reduced cross-presentation, and weak T-cell activation in the DC2.4 cell line. However, BMDCs expressed intermediate maturation marker levels and NF-κB activation without increased cytokine secretion. In contrast, nanoscale wrinkles and planar controls preserved DC immaturity with high antigen uptake and low maturation, though planar surfaces showed poor adhesion, limiting their utility for delivery or ex vivo culture. These findings identify surface topography as a key regulator of DC immune programming. Our versatile, scalable fabrication strategy provides a broadly applicable platform for probing immune cell-material interactions and advancing biomaterials for DC-based immunotherapies and related applications. STATEMENT OF SIGNIFICANCE: Immune therapies increasingly rely on dendritic cells (DCs), yet current biomaterials mainly use biochemical signals to guide their behavior. This study introduces a new approach using precisely engineered surface topographies to influence DC function through physical cues alone. By creating tunable wrinkled MXene coatings, we show for the first time that different topographical scales can maintain DC immaturity or induce maturation with either homeostatic or immunogenic polarization potential. Unlike prior studies that focus on general surface roughness or chemistry, we demonstrate a topography-specific effect validated in both cell line and primary DCs. This work establishes surface architecture as a powerful design parameter for immune-instructive biomaterials, with potential to improve vaccine development and cell-based immunotherapies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Materials and Mechanics · Immunotherapy and Immune Responses · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (92)
Show source-provided references
1. Striking a balance: new perspectives on homeostatic dendritic cell maturation10.1038/s41577-024-01079-5 ↗
2. Molecular mechanisms of dendritic cell migration in immunity and cancer10.1007/s00430-020-00680-4 ↗
3. The role of dendritic cells in the immunomodulation to implanted biomaterials10.1038/s41368-022-00203-2 ↗
4. Engineering the next generation of cell-based therapeutics10.1038/s41573-022-00476-6 ↗
5. Inducing immune tolerance with dendritic cell-targeting nanomedicines10.1038/s41565-020-00810-2 ↗
6. Next-generation stem cells — ushering in a new era of cell-based therapies10.1038/s41573-020-0064-x ↗
7. Dendritic cell-based immunotherapy10.1038/cr.2016.157 ↗
8. Revolutionizing cancer treatment: the power of dendritic cell-based vaccines in immunotherapy10.1016/j.biopha.2025.117858 ↗
9. Sipuleucel-T (Provenge) injection
10. Metabolic labeling and targeted modulation of dendritic cells10.1038/s41563-020-0680-1 ↗
11. Cryomicroneedles for transdermal cell delivery10.1038/s41551-021-00720-1 ↗
12. Injectable cryogel-based whole-cell cancer vaccines10.1038/ncomms8556 ↗
13. First-in-Human clinical trial of vaccination with WDVAX, a dendritic cell–activating scaffold incorporating autologous tumor cell lysate, in patients with metastatic melanoma
14. Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma
15. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
16. Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination10.1080/2162402X.2020.1792058 ↗
17. Dendritic cells as orchestrators of anticancer immunity and immunotherapy10.1038/s41571-024-00859-1 ↗
18. DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T-cell tolerance and inhibit diabetes
19. Dual-sized microparticle system for generating suppressive dendritic cells prevents and reverses type 1 diabetes in the nonobese diabetic mouse model10.1021/acsbiomaterials.9b00332 ↗
20. Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory T cells
21. Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis10.1155/2015/513295 ↗
22. Targeting DEC-205−DCIR2+ dendritic cells promotes immunological tolerance in proteolipid protein-induced experimental autoimmune encephalomyelitis10.1186/s10020-018-0017-6 ↗
23. Pro-regenerative biomaterials recruit immunoregulatory dendritic cells after traumatic injury10.1038/s41563-023-01689-9 ↗
24. Frontiers | depletion of donor dendritic cells ameliorates immunogenicity of both skin and hind limb transplants
25. Specific activation of the STING pathway by engineering piezoelectric hydrogel microspheres for boosting implant infection immunotherapy
26. Sipuleucel-T (Provenge®)—Autopsy of an innovative paradigm change in cancer treatment: why a single-product biotech company failed to capitalize on its breakthrough invention10.1007/s40259-015-0140-7 ↗
27. Effect of poly(lactic-co-glycolic acid) contact on maturation of murine bone marrow-derived dendritic cells
28. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation10.1002/jbm.a.30798 ↗
29. Differential functional effects of biomaterials on dendritic cell maturation10.1016/j.actbio.2012.06.006 ↗
30. Adhesive substrates modulate the activation and stimulatory capacity of non-obese diabetic mouse-derived dendritic cells10.1016/j.actbio.2010.08.026 ↗
31. Impact of molecular weight on the intrinsic immunogenic activity of poly(beta amino esters)10.1002/jbm.a.35970 ↗
32. The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses10.1039/c1nr10166h ↗
33. Graphene quantum dots suppress proinflammatory T cell responses via autophagy-dependent induction of tolerogenic dendritic cells10.1016/j.biomaterials.2017.08.040 ↗
34. Surface hydrophobicity of microparticles modulates adjuvanticity10.1039/c3tb20383b ↗
35. Facile and eco-friendly preparation of super-amphiphilic porous polycaprolactone10.1016/j.jcis.2019.11.012 ↗
36. van den Dries, K. Substrate stiffness influences phenotype and function of human antigen-presenting dendritic cells10.1038/s41598-017-17787-z ↗
37. Frontiers | stiffness regulates dendritic cell and macrophage subtype development and increased stiffness induces a tumor–associated macrophage phenotype in cancer co–cultures
38. Dendritic cell migration is tuned by mechanical stiffness of the confining space10.3390/cells10123362 ↗
39. Elastic nanovaccine enhances dendritic cell-mediated tumor immunotherapy10.1002/smll.202270173 ↗
40. Biomaterials facilitating dendritic cell-mediated cancer immunotherapy
41. Mechanical stiffness controls dendritic cell metabolism and function10.1016/j.celrep.2020.108609 ↗
42. Dendritic cell responses to surface properties of clinical titanium surfaces10.1016/j.actbio.2010.10.020 ↗
43. The interactions of dendritic cells with osteoblasts on titanium surfaces: an in vitro investigation10.1007/s00784-019-02852-w ↗
44. Effect of different titanium surfaces on maturation of murine bone marrow-derived dendritic cells
45. Precision-porous templated scaffolds of varying pore size drive dendritic cell activation10.1002/bit.26532 ↗
46. Tuning the immune cell response through surface nanotopography engineering
47. Micro/nanostructured topography on titanium orchestrates dendritic cell adhesion and activation via β2 integrin-FAK signals10.2147/IJN.S381222 ↗
48. Designer micro-/nanocrumpled MXene multilayer coatings accelerate osteogenesis and regulate macrophage polarization10.1021/acsami.3c18158 ↗
49. Stretchable nano-crumpled MXene multilayers impart long-term antibacterial surface properties
50. The dendritic cell cytoskeleton promotes T cell adhesion and activation by constraining ICAM-1 mobility10.1083/jcb.201406120 ↗
51. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow10.1016/S0022-1759(98)00204-X ↗
52. Scalable synthesis of Ti3C2Tx MXene10.1002/adem.201901241 ↗
53. Roles of exosomes in immunotherapy for solid cancers10.1038/s41419-024-06494-z ↗
54. Programming assembly of biomimetic exosomes: an emerging theranostic nanomedicine platform
55. Nonlinear analyses of wrinkles in a film bonded to a compliant substrate10.1016/j.jmps.2005.03.007 ↗
56. Engineering multifunctional surface topography to regulate multiple biological responses10.1016/j.biomaterials.2025.123136 ↗
57. Immune cell membrane protrusions as sensory organelles10.1146/annurev-cellbio-101323-022130 ↗
58. Dendritic cell podosomes are protrusive and invade the extracellular matrix using metalloproteinase MMP-1410.1242/jcs.056515 ↗
59. Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours10.1038/s41551-019-0486-0 ↗
60. Immune-modulatory alginate protects mesenchymal stem cells for sustained delivery of reparative factors to ischemic myocardium10.1039/D0BM00855A ↗
61. Polymeric biomaterial scaffolds for tumoricidal stem cell glioblastoma therapy10.1021/acsbiomaterials.0c00477 ↗
62. Tuning biomaterial surfaces to modulate host-immune reactions10.1021/acs.langmuir.5c01344 ↗
63. Developing implantable scaffolds to enhance neural stem cell therapy for post-operative glioblastoma10.1016/j.ymthe.2020.02.008 ↗
64. Mechanosensing in macrophages and dendritic cells in steady-state and disease
65. Geometry sensing by dendritic cells dictates spatial organization and PGE2-induced dissolution of podosomes10.1007/s00018-011-0908-y ↗
66. Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium/iodide symporter10.1186/s13550-017-0280-5 ↗
67. An antigen self-assembled and dendritic cell-targeted nanovaccine for enhanced immunity against cancer
68. Frontiers | utilizing murine dendritic cell line DC2.4 to evaluate the immunogenicity of subunit vaccines in vitro
69. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules
70. Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis10.1038/mi.2014.79 ↗
71. CD83: activation marker for antigen presenting cells and its therapeutic potential
72. Soluble CD83 triggers resolution of arthritis and sustained inflammation control in IDO dependent manner
73. Microglial expression of CD83 governs cellular activation and restrains neuroinflammation in experimental autoimmune encephalomyelitis10.1038/s41467-023-40370-2 ↗
74. Dendritic cell migration in inflammation and immunity10.1038/s41423-021-00726-4 ↗
75. Cell shape sensing licenses dendritic cells for homeostatic migration to lymph nodes10.1038/s41590-024-01856-3 ↗
76. Alloatti, A.; Kotsias, F.; Magalhaes, J.G.; Amigorena, S. Dendritic cell maturation and cross-presentation: timing matters! immunological reviews 2016/07/01, 272 (1). 10.1111/imr.12432.10.1111/imr.12432 ↗
77. Designer vaccine nanodiscs for personalized cancer immunotherapy10.1038/nmat4822 ↗
78. An improved CPRG colorimetric ligand-receptor signal transduction assay based on beta-galactosidase activity in mammalian BWZ-reporter cells10.1016/j.vascn.2017.11.004 ↗
79. LacZ inducible, antigen/MHC-specific T cell hybrids10.1093/intimm/6.3.369 ↗
80. Molino, N.M.; Anderson, A.K.L.; Nelson, E.L.; Wang, S.-W. Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. October 9, 2013. 10.1021/nn403085.10.1021/nn403085w ↗
81. Targeting NF-κb pathway for the therapy of diseases: mechanism and clinical study
82. NF-κb in biology and targeted therapy: new insights and translational implications
83. Mechanical stiffness controls dendritic cell metabolism and function10.1016/j.celrep.2020.108609 ↗
84. Innate control of actin nucleation determines two distinct migration behaviours in dendritic cells10.1038/ncb3284 ↗
85. Antigen-loaded upconversion nanoparticles for dendritic cell stimulation, tracking, and vaccination in dendritic cell-based immunotherapy
86. Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response
87. Fluorescent artificial antigens revealed extended membrane networks utilized by live dendritic cells for antigen uptake
88. Harnessing nanotopography and integrin–matrix interactions to influence stem cell fate10.1038/nmat3980 ↗
89. The CAR T-cell mechanoimmunology at a glance10.1002/advs.202002628 ↗
90. Dendritic cell immune potency on 2D and in 3D collagen matrices10.1039/D0BM01141J ↗
91. Biomaterials with structural hierarchy and controlled 3D nanotopography guide endogenous bone regeneration10.1126/sciadv.abg3089 ↗
92. 3D nanofabrication by volumetric deposition and controlled shrinkage of patterned scaffolds10.1126/science.aau5119 ↗